Mar 12, 2020 / 08:30PM GMT
Operator
Good day and welcome to the INOVIO Fourth Quarter 2019 Financial Results Conference Call. (Operator Instructions) Please note, this event is being recorded. I would now like to turn the conference over to Ben Matone, Senior Director of Investor Relations. Please go ahead.
Ben Matone - Inovio Pharmaceuticals, Inc. - Director of IR
Thank you, operator. Good afternoon and thank you for joining the INOVIO Pharmaceuticals' Fourth Quarter and Year-end 2019 Investor Conference Call. With me today are INOVIO's President and CEO, Dr. J. Joseph Kim; our Chief Financial Officer, Mr. Peter Kies; and Senior VP of Research and Development, Dr. Kate Broderick, who will provide an overview on INOVIO's continued efforts regarding the company's DNA vaccine, which is targeting the current COVID-19 outbreak.
Today's call is being webcast live on our website, ir.inovio.com, and a replay of today's call will be made available. Following a general business update, we will conduct a question-and-answer segment, which will be reserved for equity research analysts.
Q4 2019 Inovio Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot